Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Income Statement [Abstract]        
Revenues $ 180,000 $ 0 $ 240,000 $ 0
Costs and Expenses:        
Operating expenses (749,680) (1,750,766) (2,599,295) (4,505,526)
Research and development expenses (146,094) (563,559) (741,045) (1,322,816)
Loss before other income (expense) (715,774) (2,314,325) (3,100,340) (5,828,342)
Other income (expense)        
Other income (loss) 0 0 (26,500) (23,895)
Interest and financing expense 0 0 0 (260)
Change in fair value of derivative liabilities 0 0 0 (220,614)
Gain on extinguishment of derivative liabilities 0 0 0 3,441,752
Gain on disposition of equipment 0 6,000 0 52,968
Settlement of litigation and debt 0 0 0 (67,294)
Net loss before provision for income taxes (715,774) (2,308,325) (3,126,840) (2,645,685)
Provision for income taxes 0 0 800 800
Net loss $ (715,774) $ (2,308,325) $ (3,127,640) $ (2,646,485)
Net loss per common share, basic and diluted $ 0.00 $ (0.01) $ (0.02) $ (0.02)
Weighted average common shares outstanding, basic and diluted 180,695,547 165,168,368 180,204,377 158,515,065